Commerzbank: Scope Holds Its A-Rating as Barclays Trims Its Target and Verdi Calls the Streets

Scope has reaffirmed Commerzbank's issuer rating at A with a stable outlook, according to media reports — a verdict that sits alongside, rather than against, the more guarded stance Barclays adopted toward the equity. A confirmed credit grade is not a buy signal for the shares, and the two judgments simply weigh different things.

The rating agency neither lifted the notch nor improved the outlook. What shareholders get is continuity, not a re-rating of creditworthiness, and a stable outlook on its own implies no additional upside for the stock. Barclays, by contrast, cut Commerzbank from "Overweight" to "Equal Weight" roughly a week ago and trimmed its price target to EUR 41 from EUR 42. Read the two side by side and there is no uniformly bullish or bearish signal for the share certificate — only an issuer assessment held steady and an equity call scaled back.

Capital relief adds a second layer

Regulatory news rounds out the picture. The ECB lowered the additional own-funds requirement under Pillar 2 for 2027 by 5 basis points, leaving the add-on at 2.10%. At least 1.18% must be covered with hard core capital, and the CET1 MDA threshold stands at a pro-forma 10.26% of risk-weighted assets, calculated on the basis of the 30 June position. That threshold is not the same thing as the capital ratio actually on the books.

A lighter capital load and an unchanged credit rating are distinct statements: one concerns the equity requirement, the other the judgment on the bank as an issuer. Neither answers how the business itself is performing.

Should investors sell immediately? Or is it worth buying Commerzbank?

The deposit battle moves interest income to centre stage

That question was sharpened on 22 October, when Barclays cited tougher deposit competition and a softer-than-expected net interest result among its reasons for the downgrade. It is an expectation, not a reported figure. The publication of third-quarter 2026 results is scheduled for 5 November, and net interest income is likely to be the central test of the concerns Barclays raised.

Investors would be wise not to fixate solely on the direction of the earnings change. What Commerzbank says about deposit competition matters just as much; only together can the two be properly weighed.

What the bullish case needs — and what would break it

The friendlier scenario requires no fresh regulatory decision. It would be enough for the figures not to confirm the fears over net interest income, letting the lower capital requirement meet an operating picture less burdened than Barclays anticipates. The ongoing share buyback programme adds support: Commerzbank has continued repurchasing its own stock, and what counts for valuation is the continuation of the programme rather than a standalone tally of shares bought back. A buyback, though, is no substitute for proof on earnings. In the positive case the two strands reinforce each other — the programme runs on while the business holds up against the more cautious forecasts — and a more favourable assessment could follow without assuming any acceleration.

The opposite model is just as concrete. Should net interest income validate the cautious view and deposit competition keep biting, the lower capital requirement would not refute that operating weakness. Investors would then have to separate a regulatory improvement from a less convincing earnings picture, and the buyback would not serve as a counter-argument either — it documents execution of the programme, not an answer to Barclays' question.

A union walkout on top of the numbers

Separately, Verdi called on Friday for nationwide warning strikes in the private banking sector, affecting Commerzbank employees among others. The union pointed to the absence of an employer offer and to the upcoming collective bargaining round. For investment decisions this labour dispute is an additional watch item; no concrete earnings consequences can be derived from it, and treating it as a quantifiable burden would go beyond the confirmed facts.

One date settles the split

Until the next set of figures either confirms or dispels the worries about net interest income, the capital relief can support the friendlier reading; if competitive pressure does show up in the results, operating developments would have to carry more weight than the regulatory concession. The next concrete catalyst is the announced release. For investors this is not about repeating known capital and buyback headlines — it is about whether Commerzbank's numbers and commentary rebut or confirm the more cautious earnings expectation. That is the yardstick by which everything else should be measured.

Ad

Commerzbank Stock: New Analysis - 28 October

Fresh Commerzbank information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Commerzbank analysis...